Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1970 May;39(1):128–138. doi: 10.1111/j.1476-5381.1970.tb09562.x

Prejunctional actions of some β-adrenoceptor antagonists in the vas deferens preparation of the guinea-pig

E J Mylecharane, C Raper
PMCID: PMC1703050  PMID: 4392958

Abstract

1. The β-adrenoceptor antagonists propranolol, pronethalol, MJ 1999 and Ciba 39089-Ba reduced responses to field stimulation of the guinea-pig isolated vas deferens preparation without significantly affecting responses to exogenously added noradrenaline.

2. This prejunctional blocking action of the drugs cannot be correlated with their action as β-adrenoceptor antagonists or non-specific depressants.

3. The blockade produced was more pronounced at low (5-20 Hz) than at high (50 Hz) frequencies of stimulation.

4. The blockade was slow in onset, and once established was poorly reversed by washing the preparation over a period of 1 to 2 h.

5. The blockade produced could be reversed by dexamphetamine and cocaine.

6. These experiments suggest that the β-adrenoceptor antagonists may have some actions which closely resemble those of the adrenergic neurone blocking agent guanethidine.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aramendía P., Kaumann A. J. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999). J Pharmacol Exp Ther. 1967 Feb;155(2):259–266. [PubMed] [Google Scholar]
  2. BOURA A. L., GREEN A. F. ADRENERGIC NEURONE BLOCKING AGENTS. Annu Rev Pharmacol. 1965;5:183–212. doi: 10.1146/annurev.pa.05.040165.001151. [DOI] [PubMed] [Google Scholar]
  3. Benfey B. G., Varma D. R. Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol. Br J Pharmacol Chemother. 1966 Jan;26(1):3–8. doi: 10.1111/j.1476-5381.1966.tb01804.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blinks J. R. Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):673–685. doi: 10.1111/j.1749-6632.1967.tb41237.x. [DOI] [PubMed] [Google Scholar]
  5. CHANG C. C., COSTA E., BRODIE B. B. INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS. J Pharmacol Exp Ther. 1965 Mar;147:303–312. [PubMed] [Google Scholar]
  6. DAY M. D. Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine. Br J Pharmacol Chemother. 1962 Apr;18:421–439. doi: 10.1111/j.1476-5381.1962.tb01421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DAY M. D., RAND M. J. Evidence for a competitive antagonism of guanethidine by dexamphetamine. Br J Pharmacol Chemother. 1963 Feb;20:17–28. doi: 10.1111/j.1476-5381.1963.tb01293.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dorph S., Binder C. Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension. Acta Med Scand. 1969 May;185(5):443–448. doi: 10.1111/j.0954-6820.1969.tb07362.x. [DOI] [PubMed] [Google Scholar]
  9. Foo J. W., Jowett A., Stafford A. The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart. Br J Pharmacol. 1968 Sep;34(1):141–147. doi: 10.1111/j.1476-5381.1968.tb07957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gerkens J. F., McCulloch M. W. Mechanism of the antagonism between guanethidine and dexamphetamine. Br J Pharmacol. 1969 Mar;35(3):563–572. doi: 10.1111/j.1476-5381.1969.tb08297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HOLMAN M. E., JOWETT A. SOME ACTIONS OF CATECHOLAMINES ON THE SMOOTH MUSCLE OF THE GUINEA-PIG VAS DEFERENS. Aust J Exp Biol Med Sci. 1964 Feb;42:40–53. doi: 10.1038/icb.1964.4. [DOI] [PubMed] [Google Scholar]
  12. Kirpekar S. M., Wakade A. R., Dixon W., Prat J. C. Effect of cocaine, phenoxybenzamine and calcium on the inhibition of norepinephrine output from the cat spleen by guanthidine. J Pharmacol Exp Ther. 1969 Feb;165(2):166–175. [PubMed] [Google Scholar]
  13. LARGE B. J. SYMPATHETIC BETA-RECEPTORS AND THE GUINEA-PIG VAS DEFERENS. Br J Pharmacol Chemother. 1965 Feb;24:194–204. doi: 10.1111/j.1476-5381.1965.tb02095.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MCEWEN L. M. The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol. 1956 Mar 28;131(3):678–689. doi: 10.1113/jphysiol.1956.sp005493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MORALES AGUILERA A., VAUGHANWILLIAMS E. M. THE EFFECTS ON CARDIAC MUSCLE OF BETA-RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS. Br J Pharmacol Chemother. 1965 Apr;24:332–338. doi: 10.1111/j.1476-5381.1965.tb01719.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Obianwu H. O. Some studies on the mechanism by which d-amphetamine antagonizes guanethidine induced adrenergic neurone blockade. Acta Physiol Scand. 1969 Jan-Feb;75(1):102–110. doi: 10.1111/j.1748-1716.1969.tb04361.x. [DOI] [PubMed] [Google Scholar]
  17. Obianwu H. O., Stitzel R., Lundborg P. Subcellular distribution of [3H]amphetamine and [3H]guanethidine and their interaction with adrenergic neurons. J Pharm Pharmacol. 1968 Aug;20(8):585–594. doi: 10.1111/j.2042-7158.1968.tb09818.x. [DOI] [PubMed] [Google Scholar]
  18. PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. PRICHARD B. N. HYPOTENSIVE ACTION OF PRONETHALOL. Br Med J. 1964 May 9;1(5392):1227–1228. doi: 10.1136/bmj.1.5392.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prichard B. N., Gillam P. M. Propranolol in hypertension. Am J Cardiol. 1966 Sep;18(3):387–393. doi: 10.1016/0002-9149(66)90059-2. [DOI] [PubMed] [Google Scholar]
  21. Prichard B. N., Gillam P. M. Treatment of hypertension with propranolol. Br Med J. 1969 Jan 4;1(5635):7–16. doi: 10.1136/bmj.1.5635.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Raper C., Jowett A. Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs. Eur J Pharmacol. 1967 Sep;1(5):353–362. doi: 10.1016/0014-2999(67)90095-7. [DOI] [PubMed] [Google Scholar]
  23. Raper C., Wale J. Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias. Eur J Pharmacol. 1968 Aug;4(1):1–12. doi: 10.1016/0014-2999(68)90002-2. [DOI] [PubMed] [Google Scholar]
  24. Raper C., Wale J. Specificity of beta-receptor antagonists. Eur J Pharmacol. 1968 Jun;3(3):279–281. doi: 10.1016/0014-2999(68)90145-3. [DOI] [PubMed] [Google Scholar]
  25. SEKIYA A., VAUGHANWILLIAMS E. M. A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother. 1963 Dec;21:473–481. doi: 10.1111/j.1476-5381.1963.tb02015.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Schmid J. R., Hanna C. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. J Pharmacol Exp Ther. 1967 May;156(2):331–338. [PubMed] [Google Scholar]
  27. Waal H. J. Hypotensive action of propranolol. Clin Pharmacol Ther. 1966 Sep-Oct;7(5):588–598. doi: 10.1002/cpt196675588. [DOI] [PubMed] [Google Scholar]
  28. von Euler U. S., Lishajko F. Inhibitory action of adrenergic blocking agents on reuptake and net uptake of noradrenaline in nerve granules. Acta Physiol Scand. 1968 Nov;74(3):501–506. doi: 10.1111/j.1748-1716.1968.tb04258.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES